Pharmafile Logo
Pharmafocus logo
Advanced Search

kymab

Showing 9 posts of 9 posts found.

Sanofi to acquire Kymab for $1.1bn

January 11, 2021
Sales and Marketing Malin, Sanofi, kymab

Sanofi is to acquire clinical-stage biopharmaceutical company Kymab for approximately $1.1 billion. In addition to this upfront sum, Paris-headquartered Sanofi …

News
simon-sturge-kymab-tile

Kymab announces Merck exec Simon Sturge as new CEO

April 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim, appointment, kymab, pharma

UK-based biotech Kymab has identified Merck KGaA executive Simon Sturge as its new Chief Executive Officer, taking over the reins …

Appointment
dr_sonia_quaratino

Kymab instates first Chief Medical Officer

May 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, kymab

Kymab, a therapeutic antibody company based in Cambridge, UK, has announced that it has appointed Dr Sonia Quaratino as its …

Appointment
kymab

Chinese investors push Kymab backing to $100 million

November 28, 2016
Sales and Marketing Bill & Melina Gates Foundation, China, kymab

Kymab, the UK-based antibody biopharmaceutical group, announced that it has secured $100 million in funding. The company raised the funds …

News
hiv-infected_h9_t-cell_-_credit_national_institutes_of_health-web

Kymab demonstrates promising research for HIV vaccine development

September 9, 2016
Medical Communications, Research and Development HIV, Vaccine, kymab

Cambridge-based antibodies-to-medicines company Kymab has announced publication of research testing the first step in the effort to develop effective vaccines …

News
Janssen image

Janssen, Enterome and Kymab in research collaborations

January 7, 2016
Research and Development Crohn's, Crohn’s disease, Enterome, Janssen, MD Anderson, alliance, antibodies, collaboration, crohn's disease, immuno-oncology, kymab, research

Several pharma companies have announced new collaborations, to research potential new drugs for Crohn’s disease, and immuno-oncology treatments for cancer. …

News
anne_hyland

Kymab hires chief financial officer

February 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing anne hyland, kymab

Cambridge-based UK antibody development firm Kymab has appointed Anne Hyland as its chief financial officer.  Hyland takes to the firm …

Appointment
wells_timothy

Kymab makes appointments and executive promotions

October 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lisha Patel, Timothy Wells, jenny yip, kymab

Following a $40 million investment from The Wellcome Trust and the Bill & Melinda Gates Foundation, biopharma UK firm Kymab …

Appointment
nigel_clark

Kymab makes two senior appointments

June 5, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing arkinstall, clark, kymab

Cambridge-based biopharma firm Kymab has hired Steve 
Arkinstall as a chief scientific officer, and Nigel Clark as VP 
and head …

Appointment

Latest content

Sanofi shares results for phase 3 LUNA 3 trial in immune thrombocytopenia

April 23, 2024

FDA approves ImmunityBio’s Anktiva bladder cancer treatment

April 23, 2024

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024